187 related articles for article (PubMed ID: 29430221)
1. Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma.
Nagao Y; Nakasone K; Maeshiro T; Nishida N; Kimura K; Kawahigashi Y; Tanaka Y; Sata M
Case Rep Gastroenterol; 2017; 11(3):701-710. PubMed ID: 29430221
[TBL] [Abstract][Full Text] [Related]
2. Use of Direct-Acting Antivirals for the Treatment of Hepatitis C Virus-Associated Oral Lichen Planus: A Case Report.
Misaka K; Kishimoto T; Kawahigashi Y; Sata M; Nagao Y
Case Rep Gastroenterol; 2016; 10(3):617-622. PubMed ID: 27920651
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals.
Nagao Y; Kimura K; Kawahigashi Y; Sata M
Clin Transl Gastroenterol; 2016 Jul; 7(7):e179. PubMed ID: 27388424
[TBL] [Abstract][Full Text] [Related]
4. Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.
Yoshikawa A; Terashita K; Morikawa K; Matsuda S; Yamamura T; Sarashina K; Nakano S; Kobayashi Y; Sogabe S; Takahashi K; Haba S; Oda H; Takahashi T; Miyagishima T; Sakamoto N
Clin J Gastroenterol; 2017 Jun; 10(3):270-273. PubMed ID: 28447325
[TBL] [Abstract][Full Text] [Related]
5. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: a cohort study.
Di Stasio D; Lucchese A; Romano A; Adinolfi LE; Serpico R; Marrone A
Clin Oral Investig; 2022 Aug; 26(8):5409-5417. PubMed ID: 35477818
[TBL] [Abstract][Full Text] [Related]
6. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.
Rupp C; Hippchen T; Neuberger M; Sauer P; Pfeiffenberger J; Stremmel W; Gotthardt DN; Mehrabi A; Weiss KH
World J Gastroenterol; 2018 Mar; 24(12):1353-1360. PubMed ID: 29599610
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.
Ciesek S; Proske V; Otto B; Pischke S; Costa R; Lüthgehetmann M; Polywka S; Klempnauer J; Nashan B; Manns MP; von Hahn T; Lohse AW; Wedemeyer H; Mix H; Sterneck M
Transpl Infect Dis; 2016 Jun; 18(3):326-32. PubMed ID: 26988272
[TBL] [Abstract][Full Text] [Related]
8. Onset of Oral Lichen Planus Led to Direct-Acting Antiviral Therapy in a Patient with Long-Term Hepatitis C: The Role of a Dentist as Gatekeeper.
Nagao Y; Tsuji M
Case Rep Gastroenterol; 2023; 17(1):26-33. PubMed ID: 36742093
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
Nagao Y; Kawaguchi T; Ide T; Kumashiro R; Sata M
Int J Mol Med; 2005 Feb; 15(2):237-41. PubMed ID: 15647837
[TBL] [Abstract][Full Text] [Related]
10. No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy.
Korenaga M; Murata K; Izumi N; Tamaki N; Yokosuka O; Takehara T; Sakamoto N; Suda G; Nishiguchi S; Enomoto H; Ikeda F; Yanase M; Toyoda H; Genda T; Umemura T; Yatsuhashi H; Yamasaki K; Ide T; Toda N; Kanda T; Nirei K; Ueno Y; Haga H; Nishigaki Y; Nakane K; Omata M; Mochizuki H; Aoki Y; Imamura M; Kanto T; Mizokami M
Glob Health Med; 2022 Aug; 4(4):216-224. PubMed ID: 36119787
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP.
Mester A; Lucaciu O; Ciobanu L; Apostu D; Ilea A; Campian RS
Bosn J Basic Med Sci; 2018 Aug; 18(3):217-223. PubMed ID: 29984679
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin.
Globke B; Raschzok N; Teegen EM; Pratschke J; Schott E; Eurich D
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943544
[TBL] [Abstract][Full Text] [Related]
13. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort.
Idilman R; Demir M; Aladag M; Erol C; Cavus B; Iliaz R; Koklu H; Cakaloglu Y; Sahin M; Ersoz G; Koksal İ; Karasu Z; Ozgenel M; Turan İ; Gunduz F; Ataseven H; Akdogan M; Kiyici M; Koksal AS; Akhan S; Gunsar F; Tabak F; Kaymakoglu S; Akarca US;
J Viral Hepat; 2019 Jun; 26(6):666-674. PubMed ID: 30740820
[TBL] [Abstract][Full Text] [Related]
14. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C.
Nagao Y; Sata M; Ide T; Suzuki H; Tanikawa K; Itoh K; Kameyama T
Eur J Clin Invest; 1996 Dec; 26(12):1171-4. PubMed ID: 9013095
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation in oral lichen planus with chronic hepatitis C: the role of interferon treatment].
Sugiyama T; Shimizu M; Ohnishi H; Noguchi N; Iwata K; Kojima Y; Watanabe Y; Kawase K; Fukutomi Y; Yamauchi O; Yasuda S; Yamada M; Kobayashi S; Kojima M
Nihon Shokakibyo Gakkai Zasshi; 2000 May; 97(5):568-74. PubMed ID: 10846411
[TBL] [Abstract][Full Text] [Related]
16. Effect of hepatitis C antiviral therapy on oral lichen planus and hyposalivation in inmates.
Scelza G; Amato A; Pagano AM; Matteis G; Caruso R; Scelza A; Sisalli L; Biasi S; Marigliano F; Gagliardi M; Martina S; Iandolo A
Ann Gastroenterol; 2022; 35(1):74-79. PubMed ID: 34987292
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan.
Igarashi A; Tang W; Guerra I; Marié L; Cure S; Lopresti M
Curr Med Res Opin; 2017 Jan; 33(1):11-21. PubMed ID: 27609424
[TBL] [Abstract][Full Text] [Related]
18. Rapid Virological Response After Early Treatment with a Combined Therapy of Ledipasvir and Sofosbuvir in HCV Genotype 4 After Living Donor Liver Transplantation in a HCC Downstaged Patient: Case Report and Review of the Literature.
Obed A; Bashir A; Jarrad A
Am J Case Rep; 2016 Sep; 17():672-5. PubMed ID: 27647003
[TBL] [Abstract][Full Text] [Related]
19. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
20. The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.
Nagaoki Y; Imamura M; Nishida Y; Daijo K; Teraoka Y; Honda F; Nakamura Y; Morio K; Fujino H; Nakahara T; Kawaoka T; Tsuge M; Hiramatsu A; Kawakami Y; Miki D; Hiyama Y; Ochi H; Chayama K; Aikata H
J Med Virol; 2019 Apr; 91(4):650-658. PubMed ID: 30381831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
